Determination of debrisoquine oxidation phenotype in healthy volunteers during phase I trials

Therapie. 1996 Mar-Apr;51(2):191-2.
No abstract available

Publication types

  • Clinical Trial
  • Clinical Trial, Phase I
  • Letter

MeSH terms

  • Adolescent
  • Adult
  • Debrisoquin / metabolism*
  • Healthy Worker Effect
  • Humans
  • Male
  • Oxidation-Reduction
  • Phenotype
  • Volunteers

Substances

  • Debrisoquin